Compliance, quality management and standards in the treatment of schizophrenia

被引：8
作者：
Kissling, W
机构：
[1] Department of Psychiatry, Technische Universität, Münich
来源：
NEUROPSYCHOBIOLOGY | 1997年 / 35卷 / 02期
关键词：
schizophrenia; compliance; management; relapse;
D O I：
10.1159/000119393
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
收藏
页码：70 / 72
页数：3
相关论文
共 13 条
[1]   ASSESSMENT ISSUES AND THE COST OF SCHIZOPHRENIA [J].
ANDREASEN, NC .
SCHIZOPHRENIA BULLETIN, 1991, 17 (03) :475-481
[2]   ONE-YEAR OUTCOME OF SCHIZOPHRENIC-PATIENTS - THE INTERACTION OF CHRONICITY AND NEUROLEPTIC TREATMENT [J].
GAEBEL, W ;
PIETZCKER, A .
PHARMACOPSYCHIATRY, 1985, 18 (03) :235-239
[3]  
GMUR M, 1988, NERVENARZT, V59, P727
[4]  
KANE JM, 1985, J CLIN PSYCHOPHARM, V5, P225
[5]   COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION IN SCHIZOPHRENIA [J].
KISSLING, W .
ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 :16-24
[6]  
KISSLING W, 1992, SCHIZOPHRENIE RIFKIN, P83
[7]  
KISSLING W, 1993, ANGEHORIGENARBEIT PS, P103
[8]  
KISSLING W, 1995, MUNCHEN MED WOCHEN, V137, P801
[9]  
KISSLING W, 1988, DEPOT NEUROLEPTICS C, P41
[10]  
Kissling W., 1991, GUIDELINES NEUROLEPT
12